首页> 外文OA文献 >The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy-Drager syndrome).
【2h】

The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy-Drager syndrome).

机译:利舒利特在治疗具有自主神经功能衰竭的多系统萎缩中的应用(Shy-Drager综合征)。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In a controlled trial lisuride, an ergolene derivative with dopamine receptor agonist properties was given maximum tolerated doses (2.4 mg/day) to seven patients with multiple system atrophy with autonomic failure (Shy-Drager syndrome). Improvement in Parkinsonian features occurred in only one patient and another patient who had been deriving marked benefit from levodopa treatment before the study began failed to respond to large doses of lisuride. Psychiatric side effects (including nightmares, isolated visual hallucinations and toxic confusional states) were the dose-limiting factor in six patients. A modest reduction in orthostatic hypotension occurred in two patients, one of whom had experienced an aggravation of this disturbance on levodopa and bromocriptine. Destruction of post-synaptic dopamine receptors and damage to central noradrenergic systems may offer an explanation for the lack of therapeutic effect of lisuride.
机译:在一项有对照的试验性乙草胺中,对具有多巴胺受体激动剂特性的麦角灵衍生物给予7名患有系统衰竭(Shy-Drager综合征)的多系统萎缩患者最大耐受剂量(2.4 mg /天)。帕金森病特征的改善仅发生于一名患者,而另一名在研究开始前已从左旋多巴治疗中获得显着益处的患者未能对大剂量利苏利特产生反应。精神病学副作用(包括噩梦,孤立的幻觉和有毒的精神错乱状态)是6例患者的剂量限制因素。两名患者的体位性低血压适度降低,其中一名患者对左旋多巴和溴隐亭的干扰加剧。突触后多巴胺受体的破坏和中枢去甲肾上腺素能系统的损伤可能为利苏立德缺乏治疗效果提供了解释。

著录项

  • 作者

    Lees, A J; Bannister, R;

  • 作者单位
  • 年度 1981
  • 总页数
  • 原文格式 PDF
  • 正文语种 en
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号